📰 Adenosine News
Page 7 - Adenosine News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Adenosine. Real-time updates on events, politics, business and more.
October 11, 2022
In a new study, researchers pursued direct-acting severe acute respiratory syndrome coronavirus-2 drugs that compete for nucleotide-binding pockets (NBPs) of SARS-CoV-2 proteins.
October 7, 2022
Researchers explored the role of the ORF3c, a SARS-CoV-2 accessory protein not so extensively studied as yet.
October 5, 2022
A study led by Texas A&M AgriLife Research provides compelling evidence of the important role of hepatocyte adenosine kinase in the progression of nonalcoholic fatty liver disease, NAFLD.
September 30, 2022
Adenosine Therapy improved the quality of life of the patients by reducing asthma-related symptoms. It has also proven beneficial in helping ease coronavirus symptoms, and other respiratory problems like TB and lung cancer.
September 8, 2022
Energy supply is a vital component of economic life. And the complex interplay between society and economy is jeopardized whenever core services or key industrial sectors are at risk of failing because of energy supply problems.
August 16, 2022
A novel peptide augments the brain's natural mechanism to help prevent seizures and protect neurons in research models of both Alzheimer's and epilepsy, scientists report.
August 12, 2022
In newly released research, scientists assessed the cardiac effects of remdesivir.
June 27, 2022
The Federal Circuit noted, the relevant claim language, especially when viewed in the context of the whole claim, is not plain on its face, but rather contains evident uncertainties that weighed against U. Mass’s construction, decision might leave an open door to challenge
June 15, 2022
Researchers from Wake Forest University School of Medicine have discovered a possible new approach to treating solid tumors through the creation of a novel nanoparticle. Solid tumors are found in cancers such as breast, head and neck, and colon cancer.
May 30, 2022
Researchers at The University of Texas MD Anderson Cancer Center have developed an ultrasound-guided cancer immunotherapy platform that generates systemic antitumor immunity and improves the therapeutic efficacy of immune checkpoint blockade.